This post was originally published on this site
(Reuters) – Bayer (OTC:BAYRY) on Tuesday reported a net loss of 1.89 billion euros ($2.08 billion) for the second quarter, weighed down by 2.3 billion euros in impairment charges.
The statement based on audited results came after the German drugs and pesticides maker in July cited preliminary figures as showing expected goodwill impairments worth about 2.5 billion euros, leading to a second-quarter net loss of 2 billion euros.
